- stock
- bulk
Supplier Type
- Manufacturer
- contract manufacturer
- Trader
- custom synthesis
- Reagent
Supplier Region
- Hyderabad(53)
- Ahmedabad(21)
- Maharashtra(50)
- Delhi(22)
- Mallapur(1)
- New Delhi(9)
- Pune(12)
- Gujarat(52)
- Beijing(5)
- Mumbai(111)
- Karnataka(9)
- Andhra Pradesh(8)
- Tamil Nadu(6)
- Haryana(8)
- Vadodara(21)
- Punjab(1)
- Bangalore(2)
- Telangana(6)
- Madhya Pradesh(6)
- Uttar Pradesh(6)
- Kolkata(5)
- Kerela(1)
- West Bengal(1)
- Ujjain(1)
Purity
- Rasagiline Mesylate Impurity C
- Purity By Gc Nlt 98%
- Other
- NLT 95%
- NLT 90.00%
- N/A
- min 99.0%
- Min 99. 00%
- min 99%
- High Purity
- Greater than 99%
- good
- Glycine CAS 56-40-6 And Glycine Hydrochlroide CAS 6000-43-7
- Dipropargyl r- amino indane
- Content of Chromium 0.2 % to 0.3 %
- API Impurity / in-house working standard
- ABOVE 99%
- 99.99%
- 99.99
- 99.94%
- 99.90%
- >99.9%
- 99.9%
- 99.9 %
- 99.80 %
- 99.6
- 99.50%
- 99.5%+
- 99.5%
- 99.5 %
- 99.0% min
- 99%+
- 99% Minimum
- 99% Min
- 99% ABOVE
- > 99%
- 99%
- >99%
- 99 % +
- 99 %
- 99
- 98+
- 98.5 to 101.5%
- 98.5 %
- 98.0 %
- 98% Min
- 98%
- >98%
- 98 %
- 98
- 97-99%
- 97-99 %
- 97%
- >97%
- 97 to 98
- 96-98%
- 96% - 98%
- 96%
- 96 PURITY
- 95-99%
- 95-98%
- >95%
- 95%
- 95
- 93.0 % Min
- 93%
- >92%
- 90-95%
- 90 % Min.
- 85%
- 80-90%
- 65%
- 600
- 50%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 0MG TO GRAM
- 100Mg
- 250g
- 37kg
- 77kg
- 85kg
- 102kg
- 122kg
- 129kg
- 1000kg
- 100gms
- 500gms
- 500>
- ml
- 200kg
- 20ISO tank of MT
- 200Kg drum
- 5020050 Kg Drum / 200 Kg Drum
- 130kg
- 5gms
- 25gms
- gms
- 1g
- 5g
- 10g
- 25g
- 50g
- 100g
- 500g
- 1kg
- 1000g
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 250kg
- 500kg
- 1MT
- 5>
- 50kg drum
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 95NLT %
-
N-Benzylglycine ethyl ester
6436-90-4
-
Ethyl bromoacetate
105-36-2
-
Trinexapac-ethyl
95266-40-3
-
Tri-isodecyl trimellitate
36631-30-8
-
MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
149457-03-4
-
Ethyl trifluoroacetate
383-63-1
-
3''-Acetyl-2''-hydroxy-4-(4-phenylbutoxy)benzanilide
136450-06-1
-
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-
162012-67-1
-
N-Acetyl-L-cysteine
616-91-1
-
Ethyl 2-methylthiazole-5-carboxylate
79836-78-5
Ethyl bromoacetate 105-36-2
Trinexapac-ethyl 95266-40-3
Trimellitic acid triisodecyl ester 36631-30-8
N-[4-(2-Formylaminoacetyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide 149457-03-4
N-(3-Chloro-4-fluoro-phenyl)-7-fluoro-6-nitro-quinazolin-4-amine 162012-67-1
N-Acetyl-L-cysteine 616-91-1
Ethyl 2-methylthiazole-5-carboxylate 79836-78-5
Ethyl N-benzylideneglycinate 40682-54-0
N,N-Dimethylformamide 68-12-2

